These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4555041)

  • 21. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 23. Successive manifestations of tuberculosis in a recalcitrant patient.
    Greene ME; Stonehill RB
    J Indiana State Med Assoc; 1973 Oct; 66(10):940-2. PubMed ID: 4744506
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison between morphazinamide and pyrazinamide in retreatment of pulmonary tuberculosis].
    Zierski M
    Minerva Med; 1965 Sep; 56(71):2953-4. PubMed ID: 5322283
    [No Abstract]   [Full Text] [Related]  

  • 27. Streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis--second report. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
    Tubercle; 1970 Dec; 51(4):359-74. PubMed ID: 4924048
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical significance of the resistance to the classical tuberculostatics].
    Eule H
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):319-24. PubMed ID: 5897859
    [No Abstract]   [Full Text] [Related]  

  • 29. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 30. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 31. Observations on human infection with Mycobacterium bovis.
    Kataria YP
    Tubercle; 1969 Mar; 50(1):14-21. PubMed ID: 5813787
    [No Abstract]   [Full Text] [Related]  

  • 32. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 33. Report on the therapeutic results obtained with rifampicin.
    Böszörményi M
    Antibiot Chemother; 1970; 16():487-9. PubMed ID: 5523734
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):342-3. PubMed ID: 5897865
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of high dose INH twice weekly regimen in the original treatment for moderately advanced pulmonary tuberculosis. A report of the 12th series B study of the controlled trials].
    Kekkaku; 1972 Jun; 47(6):159-66. PubMed ID: 4562924
    [No Abstract]   [Full Text] [Related]  

  • 37. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pyrazinamide in association with streptomycin, PAS and isoniazid in the therapy of pulmonary tuberculosis].
    TODOROFF T; FRANZOSI P
    Minerva Med; 1962 Sep; 53():2667-73. PubMed ID: 13985260
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental chemotherapy of tuberculosis].
    Krebs A
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(5):417-48. PubMed ID: 4899157
    [No Abstract]   [Full Text] [Related]  

  • 40. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.